Head & Neck

MULTI-001 Nivolumab v11

MULTI-002 Carboplatin and etoposide v1

MULTI-003 Pembrolizumab v11

MULTI-010 ECX v2

MULTI-011 ECF v2

MULTI-012 ECarboX v2

MULTI-013 ECarboF v2

MULTI-018 Larotrectinib v2

MULTI-019 Entrectinib v2

MULTI-020 Dabrafenib with trametinib v3

MULTI-021 Carboplatin and paclitaxel v1

MULTI-023 Selpercatinib v2

HNT-016 TPF v9

HNT-017 CETUXIMAB (WEEKLY) with radiotherapy v4

HNT-018 TP v3

HNT-025 Carboplatin, 5-Fluorouracil and Cetuximab v3

HNT-026 Cisplatin, 5-Fluorouracil and Cetuximab for Head and Neck Cancer v3

HNT-027 T-Carbo v1

HNT-028 Cabozantinib v1

HNT-029 Lenvatinib (LENVIMA®) for thyroid cancer v1

HNT-032 Gemcitabine and Cisplatin v1